Related references
Note: Only part of the references are listed.A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron et al.
NATURE (2021)
Self-blinding citizen science to explore psychedelic microdosing
Balazs Szigeti et al.
ELIFE (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Biomaterials for Drugs Nose-Brain Transport: A New Therapeutic Approach for Neurological Diseases
Roberta Cassano et al.
MATERIALS (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Therapeutic Use of Transcranial Direct Current Stimulation in the Rehabilitation of Prolonged Disorders of Consciousness
Davide Aloi et al.
FRONTIERS IN NEUROLOGY (2021)
Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore
Thomas W. Flanagan et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Ketamine in acute phase of severe traumatic brain injury an old drug for new uses?
Daniel Agustin Godoy et al.
CRITICAL CARE (2021)
Pivotal mental states
Ari Brouwer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Cannabis in the Treatment of Traumatic Brain Injury: A Primer for Clinicians
Karl Grenier et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2020)
Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine
Zhongwei Xiong et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats
Sandor Nardai et al.
EXPERIMENTAL NEUROLOGY (2020)
Traumatic brain injury and hippocampal neurogenesis: Functional implications
John B. Redell et al.
EXPERIMENTAL NEUROLOGY (2020)
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Psychedelics as a novel approach to treating autoimmune conditions
Caitlin Thompson et al.
IMMUNOLOGY LETTERS (2020)
Relationship of Time of Injury Marijuana Exposure and Traumatic Brain Injury: A Systematic Review
Dina Elias et al.
JOURNAL OF TRAUMA NURSING (2020)
Inflammation, Infectious Triggers, and Parkinson's Disease
Elisa Caggiu et al.
FRONTIERS IN NEUROLOGY (2019)
Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments
Leandro R. D. Sanz et al.
FRONTIERS IN NEUROLOGY (2019)
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model
Balazs Nemes et al.
TRANSPLANTATION PROCEEDINGS (2019)
Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke Japan Stroke Data Bank
Susumu Kobayashi et al.
STROKE (2019)
Biosynthesis and Extracellular Concentrations of N, N-dimethyltryptamine (DMT) in Mammalian Brain
Jon G. Dean et al.
SCIENTIFIC REPORTS (2019)
Cannabis and Cannabinoid Biology in Stroke Controversies, Risks, and Promises
Sang-Ho Choi et al.
STROKE (2019)
Post-stroke inflammation-target or tool for therapy?
Kate Lykke Lambertsen et al.
ACTA NEUROPATHOLOGICA (2019)
Impact of Traumatic Brain Injury on Neurogenesis
Laura B. Ngwenya et al.
FRONTIERS IN NEUROSCIENCE (2019)
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raissa Nobrega de Almeida et al.
FRONTIERS IN PSYCHOLOGY (2019)
Psychedelics as a treatment for disorders of consciousness
Gregory Scott et al.
NEUROSCIENCE OF CONSCIOUSNESS (2019)
Appraising the entourage effect: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito et al.
BIOCHEMICAL PHARMACOLOGY (2018)
The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
Alan K. Davis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF)
Vilayanur Ramachandran et al.
NEUROCASE (2018)
The entropic brain - revisited
Robin L. Carhart-Harris
NEUROPHARMACOLOGY (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
Jia Jia et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Psychedelics as anti-inflammatory agents
Thomas W. Flanagan et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Psychedelics as Medicines: An Emerging New Paradigm
D. E. Nichols et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Serotonin and brain function: a tale of two receptors
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Potential Therapeutic Effects of Psilocybin
Matthew W. Johnson et al.
NEUROTHERAPEUTICS (2017)
Zolpidem for the Treatment of Neurologic Disorders A Systematic Review
Martin N. Bomalaski et al.
JAMA NEUROLOGY (2017)
Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke
Atsushi Mizuma et al.
FRONTIERS IN NEUROLOGY (2017)
Adult hippocampal neurogenesis poststroke: More new granule cells but aberrant morphology and impaired spatial memory
Florus Woitke et al.
PLOS ONE (2017)
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
Michael M. Schartner et al.
SCIENTIFIC REPORTS (2017)
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Vanja Dakic et al.
SCIENTIFIC REPORTS (2017)
Depression in Men and Women One Year Following Traumatic Brain Injury (TBI): A TBI Model Systems Study
Sarah Lavoie et al.
FRONTIERS IN PSYCHOLOGY (2017)
Early consciousness disorder in acute ischemic stroke: incidence, risk factors and outcome
Jie Li et al.
BMC NEUROLOGY (2016)
Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
Attila Szabo et al.
NEURAL REGENERATION RESEARCH (2016)
Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning
Alexander Barre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Targeting neutrophils in ischemic stroke: translational insights from experimental studies
Glen C. Jickling et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
Tomislav Majic et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries
Christian Moritz et al.
NEUROSCIENCE LETTERS (2015)
Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice
Olga Zhuk et al.
TOXINS (2015)
The role of serotonin and its receptors in activation of immune responses and inflammation
M. S. Shajib et al.
ACTA PHYSIOLOGICA (2015)
Sleep disturbances, TBI and PTSD: Implications for treatment and recovery
Karma Stavitsky Gilbert et al.
CLINICAL PSYCHOLOGY REVIEW (2015)
Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup
Ramon Diaz-Arrastia et al.
JOURNAL OF NEUROTRAUMA (2014)
Disorders of consciousness after acquired brain injury: the state of the science
Joseph T. Giacino et al.
NATURE REVIEWS NEUROLOGY (2014)
Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
Attila Szabo et al.
PLOS ONE (2014)
Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke
Roman Urfer et al.
STROKE (2014)
Disruption of brain connectivity in acute stroke patients with early impairment in consciousness
Yuan-Hsiung Tsai et al.
FRONTIERS IN PSYCHOLOGY (2014)
Pharmacological modulation of the state of awareness in patients with Disorders of Consciousness: an Overview
Elisa Mura et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
Felix Nau et al.
PLOS ONE (2013)
A Theoretically Based Index of Consciousness Independent of Sensory Processing and Behavior
Adenauer G. Casali et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Briony J. Catlow et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements
Arindam Pal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury
Joseph T. Giacino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke
Karsten Ruscher et al.
BRAIN (2011)
Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?
Noreen T. Boyle et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Brain-Derived Neurotrophic Factor and the Development of Structural Neuronal Connectivity
Susana Cohen-Cory et al.
DEVELOPMENTAL NEUROBIOLOGY (2010)
Neural Plasticity After Acquired Brain Injury: Evidence from Functional Neuroimaging
Haiwen Chen et al.
PM&R (2010)
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Dominique Fontanilla et al.
SCIENCE (2009)
Mirror therapy improves hand function in subacute stroke:: A randomized controlled trial
Ganes Yavuzer et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2008)
Mirror therapy enhances lower-extremity motor recovery and motor functioning after stroke:: A randomized controlled trial
Serap Sutbeyaz et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2007)
Is hippocampal atrophy a future drug target?
Vikas Dhikav et al.
MEDICAL HYPOTHESES (2007)
1,026 experimental treatments in acute stroke
VE O'Collins et al.
ANNALS OF NEUROLOGY (2006)
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial
AIR Maas et al.
LANCET NEUROLOGY (2006)
Neurogenesis in the adult is involved in the formation of trace memories
TJ Shors et al.
NATURE (2001)
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
JE Malberg et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
